Centogene NV
NASDAQ:CNTG
Centogene NV
NASDAQ:CNTG
Price:
0.3999 USD
2.54%
Market Closed
Updated:
May 14, 2024
Centogene NV
Income from Continuing Operations
|
Centogene NV
Income from Continuing Operations Peer Comparison
Comparables:
BNTX
MOR
IMTX
BIO
FYB
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Centogene NV
NASDAQ:CNTG
|
Income from Continuing Operations
-€38.7m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Income from Continuing Operations
€930.3m
|
CAGR 3-Years
296%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Income from Continuing Operations
-€456.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Income from Continuing Operations
-€97m
|
CAGR 3-Years
23%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Income from Continuing Operations
€127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Formycon AG
XETRA:FYB
|
Income from Continuing Operations
€75.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's Income from Continuing Operations?
Income from Continuing Operations
-38.7m
EUR
-38.7m
EUR
Based on the financial report for Dec 31, 2022, Centogene NV's Income from Continuing Operations amounts to -38.7m EUR.
What is Centogene NV's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-48%
-48%
Over the last year, the Income from Continuing Operations growth was 33%. The average annual Income from Continuing Operations growth rates for Centogene NV have been -23% over the past three years , -48% over the past five years .
You don't have any saved screeners yet
